← Leaderboards
Claudia K Fox
University Of Minnesota
$4,104,259
Attributed
$4,104,259
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $849K · FY2019–25$1M$750K$500K$250K$0
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$4,104,259 · 2
By mechanism
R01$4,104,259 · 2
Top collaborators
No co-investigators on record.
Most similar at University Of Minnesota
Same institution · by research overlap
- Aaron S Kelly$16,229,552
- Sharon S Allen$13,896,412
- Megan O Bensignor$1,004,600
- Eric Morris Bomberg$1,006,851
- Bradley J Segura$794,016
Others in their field
Other Emerging Leaders on “Clinical Trials”
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Bambra Strokes · Ppd Development Lp$526,656,217
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Leonard Freedman · Leidos Biomedical Research, Inc.$245,363,765
- Beth Baseler · Leidos Biomedical Research, Inc.$207,964,226
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$177,411,785
Research focus
Clinical TrialsClinically SignificantRecommendationPublic Health RelevanceRestDesignMorbid ObesityParticipantPhenterminePrimary OutcomeEnergy MetabolismEating BehaviorSafetyDesire For FoodAffectImproved OutcomeAdolescentCharacteristicsBody Mass IndexPharmaceutical PreparationsObesity TreatmentAdult ObesityDropoutComplex
Grant awards (8)
Toward Repurposing a Commonly-Used Medication for the Treatment of Pediatric Severe Obesity$309,071
R01 · FY2025 · DK · contact PI
Toward Repurposing a Commonly-Used Medication for the Treatment of Pediatric Severe Obesity$296,647
R01 · FY2024 · DK · contact PI
SMART Use of Medication for the Treatment ofAdolescent Severe Obesity$539,873
R01 · FY2023 · DK · contact PI
Toward Repurposing a Commonly-Used Medication for the Treatment of Pediatric Severe Obesity$309,144
R01 · FY2023 · DK · contact PI
SMART Use of Medication for the Treatment ofAdolescent Severe Obesity$660,609
R01 · FY2022 · DK · contact PI
SMART Use of Medication for the Treatment ofAdolescent Severe Obesity$668,894
R01 · FY2021 · DK · contact PI
SMART Use of Medication for the Treatment ofAdolescent Severe Obesity$668,894
R01 · FY2020 · DK · contact PI
SMART Use of Medication for the Treatment ofAdolescent Severe Obesity$651,127
R01 · FY2019 · DK · contact PI